Polypill Strategy for Heart Failure With Reduced Ejection Fraction
A phase 2 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 212 participants.
Also called NCT04633005
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose treatment
- Phase
- Phase 2
- Enrolled
- 212 participants
- Registry
-
NCT04633005
-
- Other papers using this trial's data
- Patient Perspectives on a Polypill Strategy for Heart Failure With Reduced Ejection Fraction: A Convergent-Parallel Mixed Methods Study Embedded in a Randomized Clinical Trial
- Polypill for heart failure with reduced ejection fraction: the POLY-HF randomized trial
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- United States
- Registry status
- Completed
Technical summary
Registry record NCT04633005. Randomized; no masking; primary purpose treatment. Start 2021-11-15 (actual); primary completion 2025-10-15 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Polypill Strategy for Heart Failure With Reduced Ejection Fraction
- Acronym
- POLY-HF
- Condition
- Heart Failure
- Intervention (Drug)
- Polypill
- Intervention (Drug)
- Control Rx
- Lead sponsor
- University of Texas Southwestern Medical Center
Record details
- Record id
cardio:ct-nct04633005- Content hash
5206537b4bdf28cfa2c60c5ed379fb34124c8edb7efa795488c818cc80ac8643